PPARγ agonist treatment reduces fibroadipose tissue in secondary lymphedema by exhausting fibroadipogenic PDGFRα+ mesenchymal cellsZiyu Chen, Shailesh Agarwal, Mengfan Wu et al.|JCI Insight|2023Cited by 14